One UGT1A1 spectrum ranges from a fasting clue to a kernicterus emergency.
Connect UGT1A1 activity to the severity of isolated unconjugated hyperbilirubinemia.
Distinguish Gilbert syndrome from Crigler-Najjar types I and II by age, bilirubin burden, and phenobarbital response.
Recognize kernicterus risk and select reassurance, phenobarbital, phototherapy, rescue therapy, or transplantation appropriately.
Bilirubin route
Follow the pigment without skipping a compartment
The route distinguishes production, transport, conjugation, excretion, and downstream clues.
Quick check
A 17-year-old develops mild scleral icterus during influenza and poor oral intake. Total bilirubin is 3.1 mg/dL, almost entirely unconjugated; CBC, reticulocytes, AST, ALT, and alkaline phosphatase are normal.
Which diagnosis is most likely?
Reason it through
Which fraction is elevated?The unconjugated fraction.
Is bilirubin production increased?No; the hemolysis studies are normal.
What triggered reduced conjugation?Intercurrent illness and fasting exposed mild UGT1A1 deficiency.
Mild, indirect, intermittent, and stressed is Gilbert until another clue breaks the pattern.
Grade the UGT1A1 spectrum
The same conjugation step produces three very different clinical burdens.
Gilbert syndrome retains substantial UGT1A1 activity and causes mild, intermittent, isolated unconjugated hyperbilirubinemia, often first recognized in adolescence.
Crigler-Najjar type I has absent or nearly absent activity, presents in infancy with severe persistent unconjugated hyperbilirubinemia, does not respond to phenobarbital, and carries a high kernicterus risk. Type II retains partial activity, is less severe, and usually lowers bilirubin with phenobarbital.
Compare phenotype, response, and risk.
Mild intermittent indirect bilirubin, normal liver tests, no progressive liver disease, and no routine treatment.
Severe neonatal indirect bilirubin, absent phenobarbital response, intensive phototherapy dependence, and transplant planning.
Moderate persistent indirect bilirubin, lower but real kernicterus risk, and a phenobarbital response.
Phenobarbital response separates residual enzyme from no useful enzyme.
Trace bilirubin to the blocked chemistry
A normal liver can still fail at one conjugation reaction.
Heme breakdown produces lipid-soluble unconjugated bilirubin, which travels bound to albumin, enters hepatocytes, and is glucuronidated by UGT1A1.
Conjugation makes bilirubin water soluble for biliary excretion. Reduced UGT1A1 leaves more unconjugated bilirubin in plasma; unbound bilirubin can cross the immature or stressed blood-brain barrier and injure deep brain nuclei.
Order the mechanism.
Macrophages break down heme and generate unconjugated bilirubin.
Albumin limits free bilirubin exposure during transport to the liver.
Hepatic uptake places bilirubin near the endoplasmic reticulum.
Glucuronic acid converts bilirubin into a water-soluble form.
Conjugated bilirubin can leave the hepatocyte and reach the intestine.
Read the bilirubin as a severity range, not a lone label
The magnitude and persistence help place the patient on the UGT1A1 spectrum.
Gilbert syndrome usually remains below about 4 mg/dL and fluctuates with triggers. Crigler-Najjar type II often falls in an intermediate range, commonly below 20 mg/dL, while untreated type I is often 20 to 50 mg/dL.
Ranges overlap and treatment decisions depend on age, albumin binding, illness, neurologic signs, and the trajectory, not a single cutoff.
Rank the patterns by neurotoxicity concern.
Intermittent bilirubin near 3 mg/dL with normal studies
Persistent bilirubin near 10 mg/dL with phenobarbital response
Bilirubin near 25 mg/dL despite treatment
Rapid rise with lethargy and opisthotonus
Use triggers and phenobarbital as discriminators
A trigger unmasks Gilbert; an inducer reveals residual UGT1A1.
Fasting, dehydration, illness, strenuous exertion, and menstruation can transiently increase bilirubin in Gilbert syndrome. Provocative fasting tests are unnecessary and are no longer recommended.
Phenobarbital induces residual UGT1A1 activity and substantially lowers bilirubin in Crigler-Najjar type II. Type I lacks a clinically meaningful response.
Select the pattern that supports Crigler-Najjar type II.
Persistent indirect hyperbilirubinemia that falls substantially with phenobarbitalThe response demonstrates residual inducible UGT1A1 activity.
Mild indirect bilirubin only during fasting with no treatment neededThat pattern supports Gilbert syndrome.
Severe neonatal indirect bilirubin with no phenobarbital responseThat pattern supports Crigler-Najjar type I.
Direct hyperbilirubinemia with urinary bilirubinThat localizes to conjugated bilirubin handling rather than UGT1A1 deficiency.
Type II moves with phenobarbital; type I does not.
Protect the brain from unbound bilirubin
The danger is not the yellow color; it is bilirubin leaving albumin and entering neural tissue.
Unconjugated bilirubin is lipid soluble and normally circulates tightly bound to albumin. Very high concentrations, acidosis, sepsis, prematurity, or albumin-displacing drugs can increase the unbound fraction.
Bilirubin neurotoxicity classically affects the basal ganglia and selected brainstem nuclei, producing acute lethargy, poor feeding, abnormal tone, arching, or seizures and potentially chronic kernicterus with movement, hearing, and gaze abnormalities.
Place the risk along the transport route.
Start at the first landmark.
Match treatment intensity to residual activity
Management ranges from reassurance to a bridge toward liver replacement.
Gilbert syndrome needs reassurance, trigger counseling, and attention to drugs affected by UGT1A1, not chronic bilirubin-lowering therapy.
Crigler-Najjar type II is usually controlled with phenobarbital plus monitoring, while illness or pregnancy can narrow the safety margin. Type I requires prolonged intensive blue-light phototherapy, often for many hours daily, with urgent rescue measures for dangerous rises and liver transplantation before irreversible kernicterus; phototherapy becomes less efficient as body surface area relative to mass falls with age.
Reveal the treatment decision for each branch.
Reassure and avoid unnecessary testing once hemolysis and liver disease are excluded.
The disorder is benign and nonprogressive.
Use phenobarbital and monitor more closely during physiologic stress.
Residual enzyme activity is inducible.
Maintain intensive phototherapy and plan timely liver transplantation.
Phototherapy is a bridge, while transplantation restores hepatic conjugation.
Escalate urgently with intensive phototherapy and specialist-directed exchange transfusion or plasma exchange as needed.
Neurotoxicity risk makes delay unacceptable.
Reassure Gilbert, induce type II, illuminate and replace type I.
Key laboratory clue
Choose the compartment that explains the pattern
Localize the defect in bilirubin handling before naming a syndrome.
Which diagnosis is most likely?
Key finding. A 17-year-old develops mild scleral icterus during influenza and poor oral intake. Total bilirubin is 3.1 mg/dL, almost entirely unconjugated; CBC, reticulocytes, AST, ALT, and alkaline phosphatase are normal.
Answer. Gilbert syndrome
Why. Mild intermittent isolated unconjugated hyperbilirubinemia triggered by illness and fasting is classic for Gilbert syndrome.
Board rule. Mild, indirect, intermittent, and stressed is Gilbert until another clue breaks the pattern.
Stage 1 of 3: Overview
Overview
Gilbert and Crigler-Najjar Syndromes
A normal liver can still fail at one conjugation reaction.
Step by step
Trace bilirubin to the blocked chemistry
1Produce bilirubinMacrophages break down heme and generate unconjugated bilirubin.
2Carry it on albuminAlbumin limits free bilirubin exposure during transport to the liver.
3Take it into hepatocytesHepatic uptake places bilirubin near the endoplasmic reticulum.
4Conjugate with UGT1A1Glucuronic acid converts bilirubin into a water-soluble form.
5Excrete into bileConjugated bilirubin can leave the hepatocyte and reach the intestine.
Clinical takeaway
Why it mattersConjugation makes bilirubin water soluble for biliary excretion. Reduced UGT1A1 leaves more unconjugated bilirubin in plasma; unbound bilirubin can cross the immature or stressed blood-brain barrier and injure deep brain nuclei.
RememberMild, indirect, intermittent, and stressed is Gilbert until another clue breaks the pattern.
Interpret the bilirubin patterns
Five patients test benign triggers, phenobarbital response, neonatal severity, acute neurotoxicity, and fraction-based differential diagnosis.
Cross out the wrong compartment and highlight the clue that localizes bilirubin handling. Each case follows the route step by step.
A 21-year-old has recurrent scleral icterus during fasting for exams. Total bilirubin is 2.8 mg/dL with a direct fraction of 0.2 mg/dL. CBC, reticulocytes, LDH, AST, ALT, and alkaline phosphatase are normal.
What is the most appropriate next step?
Reason it through
Is there hemolysis?No; CBC, reticulocytes, and LDH are normal.
Is there hepatocellular injury?No; liver enzymes are normal.
What does fasting do?It transiently unmasks reduced UGT1A1 activity.
Gilbert needs a name and reassurance, not a treatment cascade.
Is there hemolysis?Is there hepatocellular injury?
Is there hemolysis?No; CBC, reticulocytes, and LDH are normal.
Is there hepatocellular injury?No; liver enzymes are normal.
What does fasting do?It transiently unmasks reduced UGT1A1 activity.
A newborn develops severe persistent unconjugated hyperbilirubinemia above 25 mg/dL without hemolysis. Bilirubin does not fall with phenobarbital.
Which diagnosis is most likely?
Reason it through
How severe is the bilirubin burden?It is in the severe neonatal range.
What process has been excluded?Hemolytic overproduction.
What does no phenobarbital response mean?There is no useful inducible UGT1A1 activity.
Severe from birth and inducer-resistant is type I.
How severe is the bilirubin burden?What process has been excluded?
How severe is the bilirubin burden?It is in the severe neonatal range.
What process has been excluded?Hemolytic overproduction.
What does no phenobarbital response mean?There is no useful inducible UGT1A1 activity.
A 9-year-old has persistent unconjugated bilirubin around 12 mg/dL, normal liver enzymes, and no hemolysis. Bilirubin falls by more than 25 percent after phenobarbital.
Which diagnosis is most likely?
Reason it through
Is the elevation intermittent or persistent?It is persistent.
Is the burden mild or intermediate?It is intermediate rather than the typical Gilbert range.
What does the drug response prove?Residual UGT1A1 can be induced.
Intermediate plus inducible equals Crigler-Najjar type II.
Is the elevation intermittent or persistent?Is the burden mild or intermediate?
Is the elevation intermittent or persistent?It is persistent.
Is the burden mild or intermediate?It is intermediate rather than the typical Gilbert range.
What does the drug response prove?Residual UGT1A1 can be induced.
A child with Crigler-Najjar type I develops fever, dehydration, rapidly rising bilirubin, lethargy, poor suck, and backward arching despite home phototherapy.
What is the most appropriate next step?
Reason it through
What do lethargy and poor suck represent?Early acute bilirubin encephalopathy.
What does arching signal?Progressive neurologic toxicity.
What is the immediate goal?Lower unbound bilirubin before injury becomes irreversible.
Neurologic signs turn a chronic disorder into a bilirubin-removal emergency.
What do lethargy and poor suck represent?What does arching signal?
What do lethargy and poor suck represent?Early acute bilirubin encephalopathy.
What does arching signal?Progressive neurologic toxicity.
What is the immediate goal?Lower unbound bilirubin before injury becomes irreversible.
A 24-year-old has jaundice with total bilirubin 5.0 mg/dL, direct bilirubin 3.6 mg/dL, dark urine, and normal aminotransferases. There is no hemolysis.
Which feature argues most strongly against Gilbert or Crigler-Najjar syndrome?
Reason it through
Which fraction does UGT1A1 failure raise?The unconjugated fraction.
Which fraction is actually dominant?The conjugated fraction.
What category replaces UGT1A1 disease?A conjugated transport defect or another cholestatic process.
The fraction outranks the family resemblance.
Which fraction does UGT1A1 failure raise?Which fraction is actually dominant?
Which fraction does UGT1A1 failure raise?The unconjugated fraction.
Which fraction is actually dominant?The conjugated fraction.
What category replaces UGT1A1 disease?A conjugated transport defect or another cholestatic process.
Rapid review
Three questions to check
Which diagnosis is most likely?
Gilbert syndrome. Mild intermittent isolated unconjugated hyperbilirubinemia triggered by illness and fasting is classic for Gilbert syndrome.
Resident physician and founding medical reviewer at Bone Wizardry, focused on clinical accuracy, clear diagnostic reasoning, and practical board-oriented teaching across the curriculum.
